Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed MDS Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
MDS Capital Corp. was established in 1988 to participate in the financing and development of health-related technologies. Its objective is to become involved with entrepreneurs and scientists who have developed at least the basic concepts and elements of innovative products or services and who require the kinds of financial, managerial and other support MDS Capital Corp. is uniquely suited to provide.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2003 | Renovis | Series E | 45M |
| 9/2009 | Spinal Kinetics | Debt Financing | 5.3M |
| 10/2006 | Morphotek | Series D | 0 |
| 9/2006 | RenaMed Biologics | Venture Round | 0 |
| 1/2007 | Ception Therapeutics | Series C | 63M |
| 8/2005 | MAKO Surgical | Series B | 0 |
| 11/2003 | Neuromed Pharmaceuticals | Series C | 32M |
| 8/2004 | Pharmasset | Series D | 40M |
| 1/2005 | Alexza Pharmaceuticals | Series D | 0 |
| 4/2004 | Corus Pharma | Series C | 0 |
| 1/1999 | DoubleTwist | Series C | 15M |
| 2/1999 | Cytochroma | Series A | - |
| 11/2004 | ViOptix | Series C | 0 |
| 7/2002 | Alveolus | Series A | 620k |
| 2/2007 | MAKO Surgical | Series C | 0 |
| 10/2001 | Aderis Pharmaceuticals | Series D | 0 |
| 12/2000 | Neuromed Pharmaceuticals | Series A | 5M |
| 3/2001 | Neuromed Pharmaceuticals | Series B | 21M |
| 3/2004 | TransMolecular | Series C | 0 |
| 8/2002 | Archemix | Series A | 51.8M |
| 3/2003 | Corus Pharma | Series B | 40M |
| 12/2002 | TriVirix International | Series D | 25M |
| 1/2006 | Spinal Kinetics | Series B | 36M |
| 7/2004 | Alveolus | Series B | 0 |
| 6/2007 | U-Systems | Venture Round | 0 |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 11/2005 | Guava Technologies | Venture Round | 7M |
| 12/2005 | Resonant Medical | Series B | 24M |
| 5/2000 | Salu Inc | Series B | 28.5M |
| 2/2003 | Twinstrand Therapeutics | Venture Round | 6.7M |
| 4/2004 | Archemix | Series B | 50M |
| 12/2004 | Inimex Pharmaceuticals | Series A | 0 |
| 11/2005 | Adnavance Technologies | Series A | 3.9M |
| 9/2009 | Spinal Kinetics | Debt Financing | 0 |
| 6/2007 | U-Systems | Venture Round | 0 |
| 2/2007 | MAKO Surgical | Series C | 0 |
| 1/2007 | Ception Therapeutics | Series C | 0 |
| 10/2006 | Morphotek | Series D | 0 |
| 9/2006 | RenaMed Biologics | Venture Round | 0 |
| 5/2006 | KAI Pharmaceuticals | Series B | 0 |
| 1/2006 | Spinal Kinetics | Series B | 0 |
| 12/2005 | Resonant Medical | Series B | 0 |
| 11/2005 | Guava Technologies | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
